Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease.
Maple syrup urine disease (MSUD) is caused by a deficiency in the branched-chain alpha-ketoacid dehydrogenase complex. Accumulations of branched-chain amino acids (BCAAs) and branched-chain alpha-ketoacids (BCKAs) in patients with MSUD induce ketoacidosis, neurological disorders, and developmental disturbance. BCAAs and BCKAs influence on the nervous system can be estimated by analyzing these patients. According to clinical investigations on MSUD patients, leucine levels over 400 micromol/L apparently can cause any clinical problem derived from impaired function of the central nervous system. Damage to neuronal cells found in MSUD patients are presumably because of higher concentrations of both blood BCAAs or BCKAs, especially alpha-ketoisocapronic acids. These clinical data from MSUD patients provide a valuable basis on understanding leucine toxicity in the normal subject.
Mitsubuchi
Hiroshi
H
Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Japan.
Owada
Misao
M
Endo
Fumio
F
D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) / Q000378:metabolism* / Q000652:urine; D000597:Amino Acids, Branched-Chain / Q000009:adverse effects / Q000378:metabolism* / Q000502:physiology; D015415:Biomarkers; D004032:Diet; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007930:Leucine / Q000009:adverse effects* / Q000097:blood; D016031:Liver Transplantation; D008375:Maple Syrup Urine Disease / Q000235:genetics / Q000378:metabolism / Q000628:therapy
D000597:Amino Acids, Branched-Chain; D015415:Biomarkers; D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D007930:Leucine